Candriam SCA’s Mersana Therapeutics MRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
2023
Q2
$7.95M Sell
2023
Q1
$11.2M Buy
2022
Q4
$15.8M Buy
2022
Q3
$16.9M Buy
2022
Q2
$9.2M Buy
2022
Q1
$7.36M Sell
2021
Q4
$12.6M Hold
2021
Q3
$19.1M Buy
2021
Q2
$26.8M Buy
2021
Q1
$28.7M Buy
2020
Q4
$29.9M Buy
2020
Q3
$10.9M Sell
2020
Q2
$13.9M Buy
2018
Q2
Sell
2018
Q1
$568K Buy
2017
Q4
$197K Buy